Securities code: Realcan Pharmaceutical Group Co.Ltd(002589) securities abbreviation: Realcan Pharmaceutical Group Co.Ltd(002589) Announcement No.: 2022036 Realcan Pharmaceutical Group Co.Ltd(002589)
Announcement of resolutions of the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements and major omissions.
1、 Important tips
1. The general meeting of shareholders was held by a combination of on-site voting and online voting.
2. The shareholders’ meeting did not veto the proposal.
3. This meeting did not involve any change in the resolution of the previous general meeting of shareholders.
4. No proposal was added or changed during the shareholders’ meeting.
2、 Notice of meeting
The notice of Realcan Pharmaceutical Group Co.Ltd(002589) on convening the 2021 annual general meeting of shareholders was disclosed in the securities times, China Securities Journal, Securities Daily, Shanghai Securities News and cninfo.com on April 30, 2022.
3、 Basic information of the meeting
1. Convener: Board of directors
2. Meeting time: 15:00 PM, Monday, May 23, 2022
3. Meeting place: conference room on the fourth floor of the company, No. 326, Jichang Road, Yantai City, Shandong Province
4. Moderator: Mr. Han Xu, chairman
5. Meeting mode: on site meeting combined with online voting
6. The convening and convening of this meeting comply with the provisions of the company law, the rules for the general meeting of shareholders of listed companies, the Listing Rules of Shenzhen Stock Exchange, the articles of association and other relevant laws, regulations and normative documents.
4、 Attendance at the meeting
A total of 20 shareholders and their proxies participated in the voting, representing 220599303 shares, accounting for 14.66% of the total voting shares of the company. Of which:
1. One shareholder and shareholder agent attended the on-site meeting, representing 187491897 shares, accounting for 124603% of the total voting shares of the company;
2. The total number of voting shares of the company is 1076, accounting for 332.2% of the total voting shares of the company;
There were 19 minority shareholders in this meeting, representing 33107406 shares, accounting for 2.2003% of the total voting shares of the company.
3. Some directors, supervisors and senior managers of the company attended the meeting as nonvoting delegates, and lawyers of Shandong Qianyuan law firm attended the shareholders’ meeting to witness.
5、 Voting at the meeting
The shareholders’ meeting considered the following proposals by combining on-site voting and online voting, and the voting results are as follows:
1. The work report of the board of directors in 2021 was reviewed and adopted
Voting: 193628636 shares were approved, 63000 shares were opposed and 26907667 shares were abstained, accounting for 877739%, 0.0286% and 121975% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 6136739 shares in favor, 63000 shares against and 26907667 shares abstained, accounting for 185358%, 0.1903% and 812739% of the shares held by minority shareholders attending the meeting respectively.
Voting result: adopted.
2. The annual report for 2021 and its summary were considered and adopted
Voting: 220474303 shares were approved, 63000 shares were opposed and 62000 shares were abstained, accounting for 999433%, 0.0286% and 0.0281% of the voting shares attending the meeting respectively.
Among them, the total voting situation of minority shareholders: 32982406 shares agreed, 63000 shares opposed and 62000 shares abstained, accounting for 996224%, 0.1903% and 0.1873% of the shares held by minority shareholders attending the meeting respectively. Voting result: adopted.
3. The financial final accounts report for 2021 and the financial budget report for 2022 were reviewed and adopted
Voting: 214589564 shares were approved, 5947739 shares were opposed and 62000 shares were abstained, accounting for 972757%, 2.6962% and 0.0281% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 27097667 shares in favor, 5947739 shares against and 62000 shares abstained, accounting for 818478%, 179650% and 0.1873% of the shares held by minority shareholders attending the meeting respectively.
Voting result: adopted.
4. The proposal on annual profit distribution in 2021 was deliberated and passed
Voting: 220513303 shares were approved, 86000 shares were opposed and 0 shares were abstained, accounting for 999610%, 0.0390% and 0% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 33021406 shares were approved, 86000 shares were opposed and 0 shares were abstained, accounting for 997402%, 0.2598% and 0% of the shares held by minority shareholders attending the meeting respectively.
Voting result: adopted.
5. The work report of the board of supervisors in 2021 was reviewed and adopted
Voting: 220474303 shares were approved, 63000 shares were opposed and 62000 shares were abstained, accounting for 999433%, 0.0286% and 0.0281% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 32982406 shares in favor, 63000 shares against and 62000 shares abstained, accounting for 996224%, 0.1903% and 0.1873% of the shares held by minority shareholders attending the meeting respectively.. Voting result: adopted.
6. The proposal on Amending the articles of association was deliberated and adopted
Voting: 187711997 shares were approved, 6040139 shares were opposed and 26847167 shares were abstained, accounting for 850918%, 2.7381% and 121701% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 220100 shares in favor, 6040139 shares against and 26847167 shares abstained, accounting for 0.6648%, 182441% and 810911% of the shares held by minority shareholders attending the meeting respectively.
Voting result: adopted.
6、 Lawyer witness
The meeting was witnessed by Shandong Qianyuan law firm and issued the legal opinion. According to the legal opinion, the convening and convening procedures of this general meeting of shareholders, the qualifications of the participants and conveners and the deliberation and voting procedures of the meeting are in line with the provisions of laws and regulations, normative documents and the articles of association, and the voting results of the meeting are legal and effective.
7、 Documents for future reference
1. Resolution of Realcan Pharmaceutical Group Co.Ltd(002589) 2021 annual general meeting of shareholders
2. Legal opinion of Shandong Qianyuan law firm on Realcan Pharmaceutical Group Co.Ltd(002589) 2021 annual general meeting of shareholders
It is hereby announced.
Realcan Pharmaceutical Group Co.Ltd(002589) May 24, 2022
